Total Funding
1
Total FundingSeries D raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2727444
CircuLite is a cardiovascular device company, focused on developing minimally-invasive micro-pumps to treat chronic heart failures.
Acquired by 
HeartWare International
Paul Southworth: CEO and PresidentPast Role: C. R. Bard, Executive Manager
About the Company
CircuLite is a cardiovascular device company that is transforming heart failure treatment with the development of minimally-invasive micro-pumps for long-term partial circulatory support (PCS). By enabling a proactive and lower-risk treatment approach by supplementing a patient's native pumping capacity, CircuLite has the potential to improve
the quality of life for millions of chronic heart failure patients and their families. The company's proprietary micro-pump platform enables its PCS devices to be so small that they can be implanted superficially in a pacemaker-like pocket with endovascular or minimally-invasive surgical techniques.
